SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Canaccord Genuity raises Aclaris Therapeutics price target to $13 from $10

Valid market news retained in the public archive without immediate LiveCast distribution.

ACRS

Related stories